CART 19/22 T CELLS
Sponsors
Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
Conditions
Refractory/ relapsed acute lymphoblastic leukemia in childrenadolescents and young adults.
Phase 1
A Phase I Clinical Trial of CART cell therapy for refractory/ relapsed acute lymphoblastic leukemia with unmet needs in children, adolescents and young adults: feasibility and safety study (REALL_CART).
WithdrawnCTIS2023-509723-41-00
Target: 10Updated: 2024-05-07
A Phase I Clinical Trial of CART cell therapy for refractory/ relapsed acute lymphoblastic leukemia with unmet needs in children, adolescents and young adults: feasibility and safety study (REALL_CART).
RecruitingCTIS2023-509723-41-01
Start: 2025-06-16Target: 10Updated: 2025-09-29